Skip to main content
. 2022 Nov 18;2022(11):CD010671. doi: 10.1002/14651858.CD010671.pub3

Comparison 5. Yoga versus exercise.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
5.1 Back‐specific functional status 7   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
5.1.1 Back‐specific function at short term (6 weeks) 4 395 Std. Mean Difference (IV, Random, 95% CI) ‐0.04 [‐0.32, 0.23]
5.1.2 Back‐specific function at short–intermediate term (3 months) 4 575 Std. Mean Difference (IV, Random, 95% CI) ‐0.08 [‐0.28, 0.13]
5.1.3 Back‐specific function at intermediate term (6 months) 3 333 Std. Mean Difference (IV, Random, 95% CI) ‐0.08 [‐0.40, 0.23]
5.1.4 Back‐specific function at long term (12 months) 1 200 Std. Mean Difference (IV, Random, 95% CI) ‐0.02 [‐0.29, 0.26]
5.1.5 Back‐specific function at short term (1 week) – intensive intervention 1 80 Std. Mean Difference (IV, Random, 95% CI) ‐1.25 [‐1.73, ‐0.77]
5.2 Pain 6   Mean Difference (IV, Random, 95% CI) Subtotals only
5.2.1 Pain at short term (4–6 weeks) 3 201 Mean Difference (IV, Random, 95% CI) ‐12.47 [‐18.28, ‐6.66]
5.2.2 Pain at short–intermediate term (3 months) 2 326 Mean Difference (IV, Random, 95% CI) 2.68 [‐2.01, 7.36]
5.2.3 Pain at intermediate term (6 months) 3 331 Mean Difference (IV, Random, 95% CI) ‐6.41 [‐21.66, 8.83]
5.2.4 Pain at long term (12 months) 1 199 Mean Difference (IV, Random, 95% CI) 3.00 [‐4.25, 10.25]
5.2.5 Pain at short term (1 week) – intensive intervention 1 80 Mean Difference (IV, Random, 95% CI) ‐14.50 [‐22.92, ‐6.08]
5.3 Clinical improvement 3   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
5.3.1 Clinical improvement at short term (6 weeks) 2 207 Risk Ratio (M‐H, Random, 95% CI) 1.01 [0.74, 1.37]
5.3.2 Clinical improvement at short–intermediate term (3 months) 3 433 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.72, 1.31]
5.3.3 Clinical improvement at intermediate term (6 months) 1 163 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.73, 1.33]
5.4 Physical quality of life 5   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
5.4.1 Physical quality of life at short term (4–6 weeks) 3 219 Std. Mean Difference (IV, Random, 95% CI) 1.03 [0.36, 1.71]
5.4.2 Physical quality of life at short–intermediate term (3 months) 1 237 Std. Mean Difference (IV, Random, 95% CI) 0.15 [‐0.11, 0.40]
5.4.3 Physical quality of life at intermediate term (7 months) 1 54 Std. Mean Difference (IV, Random, 95% CI) 1.34 [0.75, 1.94]
5.4.4 Physical quality of life at short term (1 week) – intensive intervention 1 80 Std. Mean Difference (IV, Random, 95% CI) 1.06 [0.59, 1.53]
5.5 Mental quality of life 5   Std. Mean Difference (IV, Random, 95% CI) Subtotals only
5.5.1 Mental quality of life at short term (4–6 weeks) 3 219 Std. Mean Difference (IV, Random, 95% CI) 1.03 [‐0.44, 2.51]
5.5.2 Mental quality of life at short–intermediate term (3 months) 1 237 Std. Mean Difference (IV, Random, 95% CI) 0.16 [‐0.10, 0.41]
5.5.3 Mental quality of life at intermediate term (7 months) 1 54 Std. Mean Difference (IV, Random, 95% CI) 1.33 [0.74, 1.92]
5.5.4 Mental quality of life at short term (1 week) – intensive intervention 1 80 Std. Mean Difference (IV, Random, 95% CI) 0.87 [0.41, 1.33]
5.6 Adverse events 5 640 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.56, 1.53]
5.7 Measures of work disability 1   Mean Difference (IV, Random, 95% CI) Subtotals only
5.7.1 Sickness absenteeism at short term (6 weeks) 1 80 Mean Difference (IV, Random, 95% CI) ‐0.90 [‐4.64, 2.84]
5.7.2 Sickness absenteeism at intermediate term (6 months) 1 84 Mean Difference (IV, Random, 95% CI) ‐2.40 [‐6.00, 1.20]
5.7.3 Sickness absenteeism at long term (12 months) 1 82 Mean Difference (IV, Random, 95% CI) ‐5.90 [‐13.38, 1.58]